Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live

AstraZeneca & Pfizer

10 shared events · Importance 4 · Last updated Aug 07, 2026

Importance
4
Shared Events
10
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
55
Business
AstraZeneca: AstraZeneca is the initiator of the merger talks, seeking to expand its US presence. Its shares fell over 7% on the news, reflecting investor skepticism about the deal's value and execution risk.
Pfizer: Pfizer is referenced as a historical comparator, having attempted a hostile takeover of AstraZeneca in 2014. The current talks evoke memories of that failed bid.
Aug 02, 2026 · 60 articles
40
Business
AstraZeneca: AstraZeneca participated in the symposium, contributing to discussions on decarbonization and green chemistry.
Pfizer: Pfizer participated in the symposium, aligning with industry trends toward sustainable pharmaceutical manufacturing.
Jul 20, 2026 · 6 articles
30
Regulatory
AstraZeneca: AstraZeneca's flu vaccine portfolio could be affected by the entry of mFLUSIVA.
Pfizer: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
24
Business
AstraZeneca: Investors punished the stock over merger talks with Bristol Myers Squibb.
Pfizer: Reported upbeat quarterly results, leading to a stock gain.
Jul 14, 2026 · 280 articles
20
Regulatory
AstraZeneca: AstraZeneca, like Pfizer, previously agreed to lower prescription drug costs for United States — Medicaid, contributing to the broader context of the Trump administration's efforts to control drug prices.
Pfizer: Pfizer previously agreed to lower the cost of prescription drugs for United States — Medicaid following an executive order, setting a precedent for the current deal with Eli Lilly and Company and Novo Nordisk.
Nov 06, 2025 · 6 articles
20
Domestic
AstraZeneca: AstraZeneca's vaccine was previously suspended for under 60s in Germany in 2021 due to blood clot concerns; not directly affected by current policy.
Pfizer: Pfizer's COVID-19 vaccine (with BioNTech) may see reduced demand in Germany; the company has faced scrutiny over adverse event data.
Jul 13, 2026 · 6 articles
10
Business
AstraZeneca: AstraZeneca is mentioned as an existing AWS customer, but this event does not directly impact it.
Pfizer: Pfizer is mentioned as an existing AWS customer, but this event does not directly impact it.
Aug 10, 2026 · 7 articles
2
Business
AstraZeneca: AstraZeneca is a partner of Ascentage Pharma, but this event does not directly involve AstraZeneca.
Pfizer: Pfizer is a partner of Ascentage Pharma, but this event does not directly involve Pfizer.
Jul 26, 2026 · 6 articles
0
Regulatory
Pfizer: Pfizer had previously struck a deal with the administration to rein in prices and expects United States — Medicaid discounts to result in price and margin compression next year.
Dec 19, 2025 · 7 articles
0
Regulatory
Jun 11, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how AstraZeneca and Pfizer interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.